Oligodendroglia are limited in type i interferon induction and responsiveness in vivo

GLIA

Volumn 60, Issue 10, 2012, Pages 1555-1566

  Kapil, Parul ^a,b   Butchi, Niranjan B ^a   Stohlman, Stephen A ^a   Bergmann, Cornelia C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Central nervous system; Coronavirus; IFN ; Innate immunity; Oligodendroglia

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; DOUBLE STRANDED RNA; I KAPPA B KINASE EPSILON; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; PATTERN RECOGNITION RECEPTOR; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL LEVEL; CONTROLLED STUDY; CORONAVIRUS INFECTION; ENCEPHALOMYELITIS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IN VIVO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR UPREGULATION; TROPISM; VIRUS IMMUNITY;

ANIMALS; CALMODULIN-BINDING PROTEINS; DEAD-BOX RNA HELICASES; ENCEPHALOMYELITIS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; INTERFERON INDUCERS; INTERFERON TYPE I; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MYELIN PROTEOLIPID PROTEIN; OLIGODENDROGLIA; POLY I-C; RNA, MESSENGER; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 84865321249     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22375     Document Type: Article

References (65)

1. Akwa Y, Hassett DE, Eloranta ML, Sandberg K, Masliah E, Powell H, Whitton JL, Bloom FE, Campbell IL. 1998. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol 161: 5016-5026.
2. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
3. Barton GM. 2008. A calculated response: Control of inflammation by the innate immune system. J Clin Invest 118: 413-420.
4. Bass BL. 1997. RNA editing and hypermutation by adenosine deamination. Trends Biochem Sci 22: 157-162.
5. Bergmann CC, Lane TE, Stohlman SA. 2006. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol 4: 121-132.
6. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 2007. Interferons at age 50: Past, current, and future impact on biomedicine. Nat Rev Drug Discov 6: 975-990.
7. Brahic M, Bureau JF, Michiels T. 2005. The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol 59: 279-298.
8. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61: 1013-1021.
9. Butchi NB, Du M, Peterson KE. 2010. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 58: 650-664.
10. Cannella B, Raine CS. 2004. Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 55: 46-57.
11. Carpentier PA, Duncan DS, Miller SD. 2008. Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav Immun 22: 140-147.
12. Carty M, Bowie AG. 2011. Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem Pharmacol 81: 825-837.
13. Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, Thiel V, Ludewig B. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109: 1131-1137.
14. Colonna M. 2007. TLR pathways and IFN-regulatory factors: To each its own. Eur J Immunol 37: 306-309.
15. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M Jr, Shi PY, Diamond MS. 2010. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468: 452-456.
16. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, Michiels T. 2006. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci USA 103: 7835-7840.
17. Domanski P, Witte M, Kellum M, Rubinstein M, Hackett R, Pitha P, Colamonici OR. 1995. Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J Biol Chem 270: 21606-21611.
18. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36: 180-190.
19. Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
20. Fleming JO, Trousdale MD, El-Zaatari FA, Stohlman SA, Weiner LP. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58: 869-875.
21. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB. 2000. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev Biol 218: 259-274.
22. Gonzalez JM, Bergmann CC, Fuss B, Hinton DR, Kangas C, Macklin WB, Stohlman SA. 2005. Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes. Glia 51: 22-34.
23. Gonzalez JM, Bergmann CC, Ramakrishna C, Hinton DR, Atkinson R, Hoskin J, Macklin WB, Stohlman SA. 2006. Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination. Am J Pathol 168: 796-804.
24. Hanisch UK. 2002. Microglia as a source and target of cytokines. Glia 40: 140-155.
25. Hanke ML, Kielian T. 2011. Toll-like receptors in health and disease in the brain: Mechanisms and therapeutic potential. Clin Sci (Lond) 121: 367-387.
26. Honda K, Taniguchi T. 2006. IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644-658.
27. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, et al. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
28. Ireland DD, Stohlman SA, Hinton DR, Atkinson R, Bergmann CC. 2008. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol 82: 300-310.
29. Ireland DD, Stohlman SA, Hinton DR, Kapil P, Silverman RH, Atkinson RA, Bergmann CC. 2009. RNase L mediated protection from virus induced demyelination. PLoS Pathog 5: e1000602.
30. Jin YH, Kim SJ, So EY, Meng L, Colonna M, Kim BS. 2011. Melanoma differentiation-associated gene 5 is critical for protection against Theiler's virus-induced demyelinating disease. J Virol 86: 1531-1543.
31. Kapil P, Atkinson R, Ramakrishna C, Cua DJ, Bergmann CC, Stohlman SA. 2009. Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol 83: 5978-5986.
32. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
33. Kawai T, Akira S. 2007. Antiviral signaling through pattern recognition receptors. J Biochem 141: 137-145.
34. Kawai T, Akira S. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21: 317-337.
35. Levy DE, Garcia-Sastre A. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12: 143-156.
36. Li J, Liu Y, Zhang X. 2010. Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J Virol 84: 6472-6482.
37. Lipton HL, Liang Z, Hertzler S, Son KN. 2007. A specific viral cause of multiple sclerosis: One virus, one disease. Ann Neurol 61: 514-523.
38. Malmgaard L, Salazar-Mather TP, Lewis CA, Biron CA. 2002. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways. J Virol 76: 4520-4525.
39. Malone KE, Stohlman SA, Ramakrishna C, Macklin W, Bergmann CC. 2008. Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis. Glia 56: 426-435.
40. McKimmie CS, Johnson N, Fooks AR, Fazakerley JK. 2005. Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem Biophys Res Commun 336: 925-933.
41. Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22: 240-273 (Table of Contents).
42. Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV. 2009. Toll-like receptors in neurodegeneration. Brain Res Rev 59: 278-292.
43. Ousman SS, Wang J, Campbell IL. 2005. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol 79: 7514-7527.
44. Parra GI, Bergmann CC, Phares TW, Hinton DR, Atkinson R, Stohlman SA. 2010. Gamma interferon signaling in oligodendrocytes is critical for protection from neurotropic coronavirus infection. J Virol 84: 3111-3115.
45. Paul S, Ricour C, Sommereyns C, Sorgeloos F, Michiels T. 2007. Type I interferon response in the central nervous system. Biochimie 89: 770-778.
46. Pham AM, Tenoever BR. 2010. The IKK kinases: Operators of antiviral signaling. Viruses 2: 55-72.
47. Phares TW, Marques CP, Stohlman SA, Hinton DR, Bergmann CC. 2011. Factors supporting intrathecal humoral responses following viral encephalomyelitis. J Virol 85: 2589-2598.
48. Phares TW, Ramakrishna C, Parra GI, Epstein A, Chen L, Atkinson R, Stohlman SA, Bergmann CC. 2009. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J Immunol 182: 5430-5438.
49. Popko B, Baerwald KD. 1999. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res 24: 331-338.
50. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 82: 9829-9838.
51. Sen GC. 2001. Viruses and interferons. Annu Rev Microbiol 55: 255-281.
52. Serafini B, Columba-Cabezas S, Di Rosa F, Aloisi F. 2000. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 157: 1991-2002.
53. Sharma A, Maheshwari RK. 2009. Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain. J Gen Virol 90(Part 8): 1836-1847.
54. Shrestha B, Gottlieb D, Diamond MS. 2003. Infection and injury of neurons by West Nile encephalitis virus. J Virol 77: 13203-13213.
55. Skinner MA, Siddell SG. 1983. Coronavirus JHM: Nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acids Res 11: 5045-5054.
56. So EY, Kim BS. 2009. Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production. Glia 57: 1216-1226.
57. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathogens 4: e1000017.
58. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25: 373-381.
59. Stewart MJ, Smoak K, Blum MA, Sherry B. 2005. Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response. J Virol 79: 2979-2987.
60. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315: 1274-1278.
61. van Noort JM, Bsibsi M. 2009. Toll-like receptors in the CNS: Implications for neurodegeneration and repair. Prog Brain Res 175: 139-148.
62. Vilcek J. 2006. Fifty years of interferon research: Aiming at a moving target. Immunity 25: 343-348.
63. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. 2008. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131(Part 1): 288-303.
64. Zhou H, Perlman S. 2007. Mouse hepatitis virus does not induce Beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J Virol 81: 568-574.
65. Zust R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, Szretter KJ, Baker SC, Barchet W, Diamond MS, et al. 2011. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12: 137-143.